Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 25, 2017
Pharmacy Choice - Pharmaceutical News - Investigators from Saiseikai Central Hospital Release New Data on Endocrinology - May 25, 2017

Pharmacy News Article

 7/1/13 - Investigators from Saiseikai Central Hospital Release New Data on Endocrinology

By a News Reporter-Staff News Editor at Diabetes Week Current study results on Endocrinology have been published. According to news reporting originating from Tokyo, Japan, by NewsRx correspondents, research stated, "The aim of this study was to clarify the association between C-peptide immunoreactivity (CPR), a marker of beta cell function, and future glycemic control in patients with type 2 diabetes. We conducted a retrospective analysis of 513 consecutive patients with type 2 diabetes who were admitted to our hospital between 2000 and 2007 and followed up for 2 years."

Our news editors obtained a quote from the research from Saiseikai Central Hospital, "Serum and urinary CPR levels were measured during admission, and CPR index was calculated as the ratio of CPR to plasma glucose. The associations between these markers at baseline and glycemic control after 2 years were assessed by means of logistic regression models. After 2 years, 167 patients (32.6%) showed good glycemic control (HbA1c <6.9%). Baseline serum and urinary CPR indices were significantly associated with good glycemic control after 2 years, and the postprandial CPR to plasma glucose ratio (postprandial CPR index) showed the strongest association (odds ratio (OR) 1.29, 95% confidence interval (CI) 1.12-1.50, P = 0.001) among CPR indices. Multivariate analyses showed consistent results (OR 1.23, 95%CI 1.03-1.48, P = 0.021)."

According to the news editors, the research concluded: "Preserved beta cell function at baseline was associated with better glycemic control thereafter in patients with type 2 diabetes."

For more information on this research see: Association between beta cell function and future glycemic control in patients with type 2 diabetes. Endocrine Journal, 2013;60(4):517-523. Endocrine Journal can be contacted at: Japan Endocrine Soc, 75 Yanaginobanba Nishiiru-Masuya-Cho, Sanjou-Dori, Nakagyou-Ku, Kyoto, 604-8111, Japan (see also Endocrinology).

The news editors report that additional information may be obtained by contacting Y. Saisho, Saiseikai Cent Hosp, Dept. of Internal Med, Tokyo 1080073, Japan.

Keywords for this news article include: Asia, Tokyo, Japan, Endocrinology, Type 2 Diabetes Mellitus, Non-Insulin Dependent Diabetes Mellitus

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC



(c) 2013 Diabetes Week via NewsRx.com

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
May 25: Acne Vulgaris: Comprehensive Pharmaceutical Care
Last Chance
May 26: Dispensing Controlled Substances in Today’s Pharmacy
May 30: The American Geriatric Society Beers Criteria: Implications for Pharmacy Practice
May 31: Medication Safety & Drug Safety Alerts
Jun 01: Adult Immunizations: A Guide for Pharmacists, Techs & NPs
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415